Nectar Lifesciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	-1,137	49.95	-241.83	250.47	-732.64
Depreciation & Amortization	623.89	607.18	591.19	569.68	602.53
Loss (Gain) From Sale of Assets	0.14	-	-404.08	-94.07	1.31
Loss (Gain) From Sale of Investments	-0.35	-1.8	-1.05	-0.03	-0.4
Provision & Write-off of Bad Debts	16.08	9.33	2.23	9.65	-54.75
Other Operating Activities	271.92	893.53	610.79	859.77	803.16
Change in Other Net Operating Assets	1,920	688.67	779.26	-645.42	-405.42
Operating Cash Flow	1,694	2,247	1,337	950.05	213.79
Operating Cash Flow Growth	-24.59%	68.11%	40.68%	344.38%	-92.50%
Capital Expenditures	-437.95	-294.15	-300.6	-249.7	-312.41
Sale of Property, Plant & Equipment	0.08	-	797.88	397.31	1.85
Investment in Securities	-	-	2.5	-	-2.5
Other Investing Activities	18.57	123.9	17.26	18.83	26.82
Investing Cash Flow	-419.3	-170.25	517.04	166.44	-286.24
Short-Term Debt Issued	279.97	-	-	-	922.92
Long-Term Debt Issued	-	4.12	0.01	1,568	330.82
Total Debt Issued	279.97	4.12	0.01	1,568	1,254
Short-Term Debt Repaid	-	-466.94	-438.58	-2,063	-
Long-Term Debt Repaid	-815.11	-720.11	-652.39	-10.28	-7.28
Total Debt Repaid	-815.11	-1,187	-1,091	-2,073	-7.28
Net Debt Issued (Repaid)	-535.14	-1,183	-1,091	-505.69	1,246
Common Dividends Paid	-	-	-	-	-11.21
Other Financing Activities	-745.78	-871.42	-764.87	-688.11	-1,120
Financing Cash Flow	-1,281	-2,054	-1,856	-1,194	114.9
Net Cash Flow	-5.84	22.26	-2.28	-77.31	42.45
Free Cash Flow	1,256	1,953	1,036	700.35	-98.62
Free Cash Flow Growth	-35.66%	88.50%	47.91%	-	-
Free Cash Flow Margin	7.52%	11.59%	6.80%	4.20%	-0.64%
Free Cash Flow Per Share	5.60	8.71	4.62	3.12	-0.44
Cash Interest Paid	745.78	871.42	794.87	788.1	1,120
Cash Income Tax Paid	-	-	-	-	37.13
Levered Free Cash Flow	-171.02	970.9	259.57	-492.06	2,091
Unlevered Free Cash Flow	310.57	1,531	777.06	-54.91	2,627
Change in Working Capital	1,920	688.67	779.26	-645.42	-405.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.